U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07483749) titled 'HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors' on March 02.
Brief Summary: This study aims to construct a structuralized follow-up model for survivors of childhood hematological malignancies in China. Using a multicenter prospective cohort design, it will identify the burden and risk factors of late effects. The study hypothesizes that a standardized follow-up path managed by an electronic platform will improve follow-up compliance and reduce the missed diagnosis rate of late effects.
Study Start Date: March 25
Study Type: OBSERVATIONAL
Condition:
Acute Lymphoblastic Leukemia
Acute Myelo...